Results 91 to 100 of about 2,402,468 (250)
Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use. [PDF]
, 2023 INTRODUCTION: Screening for opioid misuse and treatment for opioid use disorder are critical for reducing morbidity and mortality. We sought to understand the extent of self-reported past 30-day buprenorphine use in various settings among women of ...
Cox, Shanna +6 more
core +1 more source
Evaluating diversion and treatment policies for opioid use disorder [PDF]
arXiv, 2023 The United States (US) opioid crisis contributed to 81,806 fatalities in 2022. It has strained hospitals, treatment facilities, and law enforcement agencies due to the enormous resources and procedures needed to respond to the crisis. As a result, many individuals who use opioids never receive or finish the treatment they need and instead have many ...
arxiv
EE317 Real-World Economic Benefit of Naloxone Use Among Illicit-Use Opioid Overdose Patients and Respiratory Comorbidity on Medication for Opioid Use Disorder (MOUD) [PDF]
, 2022 A Changolkar, G Owens, MK Sindhwani
openalex +1 more source
Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy
The American Journal on Addictions, EarlyView.Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage +3 more
wiley +1 more source
Patterns of Medication for Opioid Use Disorder During Pregnancy, 7 Clinical Sites, MATernaL and Infant clinical NetworK (MAT-LINK), 2014-2021. [PDF]
OBJECTIVES: To describe patterns of medication for opioid use disorder (MOUD) during pregnancies in the opioid use disorder (OUD) cohort of MAT-LINK, a sentinel surveillance network of pregnancies at US clinical sites.
Caveglia, Sarah +21 more
core +1 more source
Equitable Data-Driven Facility Location and Resource Allocation to Fight the Opioid Epidemic [PDF]
arXiv, 2023 The opioid epidemic is a crisis that has plagued the United States (US) for decades. One central issue is inequitable access to treatment for opioid use disorder (OUD), which puts certain populations at a higher risk of opioid overdose. We integrate a predictive dynamical model and a prescriptive optimization problem to compute high-quality opioid ...
arxiv
Addiction Science & Clinical Practice, 2022 Background To address the US opioid epidemic, there is an urgent clinical need to provide persons with opioid use disorder (OUD) with effective medication treatments for OUD (MOUD).
Ismene Petrakis +16 more
doaj +1 more source
Annals of Medicine, 2023 Research objective Medications for opioid use disorder (MOUDs) – including methadone, buprenorphine, and naltrexone – are the most effective treatments for opioid use disorder (OUD).
Barbara Andraka-Christou +6 more
doaj +1 more source
Journal of Advanced Nursing, EarlyView.ABSTRACT Aims To explore how nurse practitioners experienced and understood development of their capability providing medication for opioid use disorder and safe supply in North American primary care settings. Design A phenomenographic approach was applied to the study design, recruitment, and analysis. Methods Semi‐structured interviews were conducted
Martha M. Whitfield +4 more
wiley +1 more source
Frontiers in Psychiatry, 2022 IntroductionAcross the U.S., the prevalence of opioid use disorder (OUD) and the rates of opioid overdoses have risen precipitously in recent years. Several effective medications for OUD (MOUD) exist and have been shown to be life-saving.
Lisa A. Marsch +24 more
doaj +1 more source